RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Experimental Arthritis
Accession: DOID:9002457
browse the term
Definition: ARTHRITIS that is induced in experimental animals. Immunological methods and infectious agents can be used to develop experimental arthritis models. These methods include injections of stimulators of the immune response, such as an adjuvant (ADJUVANTS, IMMUNOLOGIC) or COLLAGEN.
Synonyms: exact_synonym: Adjuvant Arthritis; Arthritis, Adjuvant-Induced; Collagen Arthritides; Collagen Arthritis; Collagen-Induced Arthritides; Collagen-Induced Arthritis
primary_id: MESH:D001169
xref: EFO:1001787
GViewer not supported for the selected species.
G
Abcb1
ATP binding cassette subfamily B member 1
ISO
mRNA:altered expression:liver CTD Direct Evidence: marker/mechanism mRNA:decreased expression:intestinal mucosa (rat)
RGD CTD
PMID:17827786 PMID:19152228
RGD:11040994 RGD:2315573
NCBI chrNW_004955432:4,911,774...5,085,349
G
Abcc6
ATP binding cassette subfamily C member 6
ISO
mRNA:decreased expression:kidney
RGD
PMID:22974786
RGD:11038789
NCBI chrNW_004955442:865,292...921,739
Ensembl chrNW_004955442:865,238...922,221
G
Abcg2
ATP binding cassette subfamily G member 2 (JR blood group)
ISO
mRNA:decreased expression:small intestine
RGD
PMID:19152228
RGD:2315573
NCBI chrNW_004955474:12,365,903...12,408,715
G
Acan
aggrecan
treatment
ISO
RGD
PMID:25821409
RGD:12879456
NCBI chrNW_004955416:16,125,536...16,186,046
G
Acsl1
acyl-CoA synthetase long chain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18988084
NCBI chrNW_004955403:24,190,674...24,235,354
Ensembl chrNW_004955403:24,190,674...24,236,780
G
Acsl4
acyl-CoA synthetase long chain family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18988084
NCBI chrNW_004955490:6,143,833...6,228,395
Ensembl chrNW_004955490:6,143,833...6,228,452
G
Acsl5
acyl-CoA synthetase long chain family member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18988084
NCBI chrNW_004955431:17,477,113...17,524,539
Ensembl chrNW_004955431:17,477,086...17,524,539
G
Adam10
ADAM metallopeptidase domain 10
ISO
RGD
PMID:23897050
RGD:13703039
NCBI chrNW_004955450:15,853,372...15,927,966
Ensembl chrNW_004955450:15,853,366...15,928,200
G
Adam17
ADAM metallopeptidase domain 17
ISO
RGD
PMID:23897050
RGD:13703039
NCBI chrNW_004955487:5,180,241...5,218,298
Ensembl chrNW_004955487:5,180,252...5,218,216
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19026984 PMID:21681567 PMID:23326410
RGD:5685385 RGD:5686814
NCBI chrNW_004955420:20,911,181...20,922,992
Ensembl chrNW_004955420:20,912,348...20,914,402
G
Adk
adenosine kinase
ISO
RGD
PMID:11160636
RGD:6482663
NCBI chrNW_004955437:17,279,541...17,786,140
Ensembl chrNW_004955437:17,279,240...17,786,079
G
Ahcy
adenosylhomocysteinase
ISO
RGD
PMID:11123369
RGD:1598898
NCBI chrNW_004955422:26,992,295...27,013,100
Ensembl chrNW_004955422:26,992,295...27,013,100
G
Ahr
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25194622
NCBI chrNW_004955410:20,428,531...20,459,482
Ensembl chrNW_004955410:20,428,546...20,456,836
G
Akt1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:22391142
RGD:10041007
NCBI chrNW_004955538:3,208,711...3,224,386
Ensembl chrNW_004955538:3,208,710...3,229,904
G
Alb
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20472598
NCBI chrNW_004955447:9,327...21,212
G
Alox15
arachidonate 15-lipoxygenase
ISO
RGD
PMID:19675173
RGD:5509599
NCBI chrNW_004955467:10,032,792...10,039,789
G
Anxa1
annexin A1
ISO
RGD
PMID:10403283 PMID:23267026
RGD:2306928 RGD:7421573
NCBI chrNW_004955512:5,686,508...5,703,645
G
Anxa2
annexin A2
ameliorates
ISO
RGD
PMID:24819400
RGD:150519886
NCBI chrNW_004955450:14,545,586...14,574,161
Ensembl chrNW_004955450:14,512,381...14,574,696
G
Apoa4
apolipoprotein A4
ISO
protein:decreased expression:blood serum (rat)
RGD
PMID:10892728
RGD:5685694
NCBI chrNW_004955412:18,158,095...18,160,636
Ensembl chrNW_004955412:18,155,801...18,160,701
G
Arrb1
arrestin beta 1
ISO
protein:increased expression:knee, synoviocyte (rat)
RGD
PMID:20965243
RGD:5509895
NCBI chrNW_004955414:16,478,843...16,568,050
Ensembl chrNW_004955414:16,478,843...16,562,135
G
Arrb2
arrestin beta 2
ISO
protein:increased expression:knee, synoviocyte (rat)
RGD
PMID:20965243
RGD:5509895
NCBI chrNW_004955467:10,109,985...10,118,687
Ensembl chrNW_004955467:10,110,003...10,123,022
G
Atic
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
ISO
RGD
PMID:17408934
RGD:5144054
NCBI chrNW_004955457:704,213...729,702
Ensembl chrNW_004955457:704,213...730,134
G
Bax
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:21199477 PMID:22978269
RGD:10054249 RGD:10054498
NCBI chrNW_004955559:1,695,960...1,700,246
Ensembl chrNW_004955559:1,695,960...1,700,244
G
Bcl2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:21199477 PMID:22978269
RGD:10054249 RGD:10054498
NCBI chrNW_004955402:46,911,125...47,084,214
Ensembl chrNW_004955402:46,916,266...47,084,485
G
Bdkrb1
bradykinin receptor B1
ISO
RGD
PMID:15001555
RGD:1625760
NCBI chrNW_004955438:16,500,219...16,505,394
Ensembl chrNW_004955438:16,500,633...16,501,691
G
Bglap
bone gamma-carboxyglutamate protein
ISO
protein:decreased expression:serum
RGD
PMID:21406003
RGD:6483549
NCBI chrNW_004955545:2,381,091...2,382,114
Ensembl chrNW_004955545:2,381,156...2,381,978
G
Btk
Bruton tyrosine kinase
treatment
ISO
RGD
PMID:22228807 PMID:32083858
RGD:11040701 RGD:151665122
NCBI chrNW_004955503:7,483,819...7,515,085
Ensembl chrNW_004955503:7,482,793...7,515,120
G
C3
complement C3
treatment
ISO
RGD
PMID:7347767 PMID:20051658
RGD:11041098 RGD:7411688
NCBI chrNW_004955495:2,796,601...2,824,233
Ensembl chrNW_004955495:2,796,663...2,824,697
G
Cabin1
calcineurin binding protein 1
ISO
RGD
PMID:22275266
RGD:10054391
NCBI chrNW_004955455:8,162,365...8,312,932
Ensembl chrNW_004955455:8,162,315...8,312,909
G
Cat
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22450443
NCBI chrNW_004955422:11,783,973...11,826,970
Ensembl chrNW_004955422:11,781,835...11,827,464
G
Cbl
Cbl proto-oncogene
treatment
ISO
RGD
PMID:16984225
RGD:2306289
NCBI chrNW_004955412:20,307,011...20,388,539
Ensembl chrNW_004955412:20,307,011...20,388,539
G
Cblb
Cbl proto-oncogene B
ISO
RGD
PMID:16984225
RGD:2306289
NCBI chrNW_004955427:6,601,651...6,812,896
Ensembl chrNW_004955427:6,604,820...6,812,882
G
Ccl5
C-C motif chemokine ligand 5
ISO
mRNA, protein:increased expression:synovium, monocytes
RGD
PMID:9637726 PMID:17052673
RGD:2307143 RGD:4889940
NCBI chrNW_004955481:10,293,758...10,301,118
Ensembl chrNW_004955481:10,293,399...10,301,143
G
Ccn1
cellular communication network factor 1
ameliorates
ISO
RGD
PMID:27653023
RGD:150429754
NCBI chrNW_004955423:8,416,498...8,419,029
Ensembl chrNW_004955423:8,413,725...8,419,166
G
Ccr2
C-C motif chemokine receptor 2
ISO
RGD
PMID:16320322
RGD:4144893
NCBI chrNW_004955420:25,641,184...25,664,413
G
Cd28
CD28 molecule
ISO
RGD
PMID:18601859
RGD:2307202
NCBI chrNW_004955457:11,159,769...11,253,099
Ensembl chrNW_004955457:11,162,282...11,192,991
G
Cd4
CD4 molecule
treatment
ISO
RGD
PMID:12010568 PMID:15479897
RGD:10058957 RGD:10058960
NCBI chrNW_004955413:4,400,326...4,422,110
Ensembl chrNW_004955413:4,408,390...4,421,535
G
Cd40
CD40 molecule
ISO
RGD
PMID:20435931
RGD:5490544
NCBI chrNW_004955445:11,191,817...11,202,156
Ensembl chrNW_004955445:11,190,603...11,202,093
G
Cd40lg
CD40 ligand
treatment
ISO
protein:increased expression:plasma (rat)
RGD
PMID:7689748 PMID:22611405 PMID:27218142
RGD:11344958 RGD:11352298 RGD:11352696
NCBI chrNW_004955489:8,465,571...8,477,714
Ensembl chrNW_004955489:8,465,164...8,477,746
G
Cd44
CD44 molecule (IN blood group)
ISO
protein:increased expression:joint, macrophage, lymphocyte
RGD
PMID:8639178
RGD:2289388
NCBI chrNW_004955422:11,106,061...11,189,951
G
Cd46
CD46 molecule
ISO
RGD
PMID:21852528
RGD:6483461
NCBI chrNW_004955406:43,002,817...43,034,555
G
Cd59
CD59 molecule (CD59 blood group)
ISO
RGD
PMID:14519760
RGD:1600483
NCBI chrNW_004955422:12,500,572...12,528,738
G
Cd69
CD69 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12882836
NCBI chrNW_004955413:5,579,037...5,586,238
Ensembl chrNW_004955413:5,579,072...5,587,491
G
Cd80
CD80 molecule
ISO
RGD
PMID:22004797
RGD:6902903
NCBI chrNW_004955427:19,237,251...19,274,001
Ensembl chrNW_004955427:19,236,445...19,261,517
G
Cdc42
cell division cycle 42
ISO
protein:increased activation:bone marrow, macrophage
RGD
PMID:21266780
RGD:5688271
NCBI chrNW_004955452:2,255,940...2,299,042
Ensembl chrNW_004955452:2,255,117...2,299,042
G
Col2a1
collagen type II alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16200597 PMID:21188452 PMID:23326410 PMID:24709313 PMID:25194622 PMID:25481498 PMID:26070417 PMID:29908986 PMID:29935983 PMID:36181686 More...
NCBI chrNW_004955500:6,860,771...6,885,466
Ensembl chrNW_004955500:6,860,771...6,885,473
G
Cp
ceruloplasmin
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19205849 PMID:19330884
RGD:2314686
NCBI chrNW_004955448:470,063...522,909
Ensembl chrNW_004955448:473,179...523,100
G
Cpox
coproporphyrinogen oxidase
ISO
protein:decreased activity:liver (rat)
RGD
PMID:9173682
RGD:1600958
NCBI chrNW_004955427:152,397...163,570
Ensembl chrNW_004955427:152,894...164,030
G
Crhr1
corticotropin releasing hormone receptor 1
ISO
RGD
PMID:17550594
RGD:1626231
NCBI chrNW_004955478:10,380,185...10,390,838
Ensembl chrNW_004955478:10,379,287...10,404,825
G
Csf1
colony stimulating factor 1
ISO
protein:increased expression:dorsal root ganglion
RGD
PMID:32510872
RGD:127338469
NCBI chrNW_004955435:13,404,236...13,423,059
Ensembl chrNW_004955435:13,404,508...13,424,247
G
Csf1r
colony stimulating factor 1 receptor
treatment
ISO
RGD
PMID:18434589
RGD:151665814
NCBI chrNW_004955415:4,434,486...4,462,505
Ensembl chrNW_004955415:4,434,453...4,461,751
G
Csf3
colony stimulating factor 3
treatment
ISO
RGD
PMID:12742377
RGD:11039465
NCBI chrNW_004955451:14,688,181...14,690,126
Ensembl chrNW_004955451:14,688,181...14,690,126
G
Csk
C-terminal Src kinase
ISO
RGD
PMID:10411542
RGD:5134371
NCBI chrNW_004955450:3,127,561...3,144,550
Ensembl chrNW_004955450:3,127,561...3,144,550
G
Ctla4
cytotoxic T-lymphocyte associated protein 4
treatment
ISO
RGD
PMID:7543497 PMID:22354915
RGD:7204500 RGD:7204519
NCBI chrNW_004955457:11,028,707...11,034,898
Ensembl chrNW_004955457:11,028,698...11,073,460
G
Ctsb
cathepsin B
ISO
mRNA:increased expression:knee joint, synovium (rat)
RGD
PMID:17195213
RGD:2315521
NCBI chrNW_004955403:53,086,236...53,100,217
Ensembl chrNW_004955403:53,085,574...53,093,809
G
Ctsk
cathepsin K
ISO
mRNA:increased expression:synovium, bone marrow
RGD
PMID:15353610
RGD:1601025
NCBI chrNW_004955588:149,036...158,093
Ensembl chrNW_004955588:148,748...158,093
G
Ctss
cathepsin S
ISO
RGD
PMID:21439785
RGD:5686915
NCBI chrNW_004955413:99,279...124,793
Ensembl chrNW_004955413:99,159...124,042
G
Cx3cl1
C-X3-C motif chemokine ligand 1
ISO
RGD
PMID:11465708
RGD:4892002
NCBI chrNW_004955433:15,023,272...15,034,650
Ensembl chrNW_004955433:15,023,050...15,034,711
G
Cx3cr1
C-X3-C motif chemokine receptor 1
ISO
protein:increased expression:spinal cord
RGD
PMID:11465708 PMID:17123734
RGD:4891969 RGD:4892002
NCBI chrNW_004955427:24,691,206...24,705,599
Ensembl chrNW_004955427:24,701,073...24,707,230
G
Ddr2
discoidin domain receptor tyrosine kinase 2
ameliorates
ISO
RGD
PMID:24819400
RGD:150519886
NCBI chrNW_004955462:13,578,638...13,644,834
Ensembl chrNW_004955462:13,584,724...13,642,968
G
Dhodh
dihydroorotate dehydrogenase (quinone)
ISO
RGD
PMID:15182735
RGD:2316231
NCBI chrNW_004955484:4,699,743...4,713,466
Ensembl chrNW_004955484:4,699,722...4,713,466
G
Dnmt1
DNA methyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25194984
NCBI chrNW_004955495:1,465,529...1,505,379
Ensembl chrNW_004955495:1,465,480...1,505,462
G
Drd1
dopamine receptor D1
treatment
ISO
mRNA:increased expression:corpus striatum (rat)
RGD
PMID:23762129
RGD:7248592
NCBI chrNW_004955408:28,003,229...28,006,595
Ensembl chrNW_004955408:28,003,229...28,006,595
G
Drd2
dopamine receptor D2
treatment
ISO
mRNA:increased expression:corpus striatum (rat)
RGD
PMID:23762129
RGD:7248592
NCBI chrNW_004955412:15,054,255...15,114,558
Ensembl chrNW_004955412:15,054,038...15,114,573
G
Edn1
endothelin 1
ISO
mRNA:increased expression:inguinal lymph node (mouse)
RGD
PMID:22249931
RGD:8661695
NCBI chrNW_004955465:2,287,906...2,314,945
Ensembl chrNW_004955465:2,287,798...2,314,753
G
Egfr
epidermal growth factor receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7589090
NCBI chrNW_004955456:321,222...456,431
G
Esr1
estrogen receptor 1
treatment
ISO
associated with Osteoporosis
RGD
PMID:20112355
RGD:10045851
NCBI chrNW_004955439:9,588,631...9,953,606
Ensembl chrNW_004955439:9,588,201...9,963,353
G
Esr2
estrogen receptor 2
ISO
RGD
PMID:16269464
RGD:5508854
NCBI chrNW_004955466:5,587,003...5,644,765
Ensembl chrNW_004955466:5,575,088...5,638,946
G
F2
coagulation factor II, thrombin
ISO
RGD
PMID:21436072
RGD:5147764
NCBI chrNW_004955422:1,356,675...1,367,788
Ensembl chrNW_004955422:1,356,769...1,367,517
G
F2r
coagulation factor II thrombin receptor
severity
ISO
RGD
PMID:19674841
RGD:7387269
NCBI chrNW_004955425:24,144,905...24,164,498
G
F2rl1
F2R like trypsin receptor 1
ISO
RGD
PMID:12511586
RGD:735010
NCBI chrNW_004955425:24,050,901...24,054,039
G
Faslg
Fas ligand
treatment
ISO
RGD
PMID:22354915
RGD:7204500
NCBI chrNW_004955406:13,098,479...13,107,045
Ensembl chrNW_004955406:13,098,662...13,107,389
G
Fcgr2b
Fc fragment of IgG receptor IIb
ISO
RGD
PMID:23341540
RGD:11344930
NCBI chrNW_004955462:14,639,396...14,653,801
G
Fgf8
fibroblast growth factor 8
ISO
RGD
PMID:18699993
RGD:2314157
NCBI chrNW_004955485:8,517,412...8,521,732
Ensembl chrNW_004955485:8,517,412...8,521,770
G
Fgfr1
fibroblast growth factor receptor 1
ISO
RGD
PMID:22833219
RGD:10402072
NCBI chrNW_004955463:14,013,247...14,064,354
Ensembl chrNW_004955463:14,013,247...14,064,111
G
Flt1
fms related receptor tyrosine kinase 1
ISO
RGD
PMID:19180491
RGD:6483591
NCBI chrNW_004955497:7,653,309...7,831,737
Ensembl chrNW_004955497:7,653,248...7,831,472
G
Flt3
fms related receptor tyrosine kinase 3
ISO
RGD
PMID:10857786
RGD:61066
NCBI chrNW_004955497:7,357,533...7,441,215
Ensembl chrNW_004955497:7,357,212...7,461,439
G
Foxp3
forkhead box P3
treatment
ISO
mRNA,protein:decreased expression:lung
RGD
PMID:23643080 PMID:29264841
RGD:38549364 RGD:38599003
NCBI chrNW_004955543:731,707...742,606
Ensembl chrNW_004955543:731,707...742,606
G
Gja1
gap junction protein alpha 1
ISO
RGD
PMID:23165424
RGD:7207259
NCBI chrNW_004955436:3,612,533...3,618,095
Ensembl chrNW_004955436:3,612,533...3,618,095
G
Gli1
GLI family zinc finger 1
treatment
ISO
RGD
PMID:25821409
RGD:12879456
NCBI chrNW_004955458:5,181,761...5,193,500
Ensembl chrNW_004955458:5,185,225...5,193,196
G
Gpi
glucose-6-phosphate isomerase
ISO
RGD
PMID:23911657
RGD:11051957
NCBI chrNW_004955468:3,980,999...4,007,553
Ensembl chrNW_004955468:3,980,999...4,008,652
G
Grk2
G protein-coupled receptor kinase 2
treatment disease_progression
ISO
protein:altered expression:T cell (rat) protein:increased expression:aorta (rat)
RGD
PMID:28349925 PMID:28631356 PMID:28653218
RGD:13513975 RGD:13513976 RGD:13513979
NCBI chrNW_004955422:18,173,438...18,192,357
Ensembl chrNW_004955422:18,170,616...18,192,412
G
Grn
granulin precursor
ISO
RGD
PMID:21393509
RGD:5509782
NCBI chrNW_004955451:17,368,600...17,371,981
Ensembl chrNW_004955451:17,368,428...17,372,377
G
Gsk3b
glycogen synthase kinase 3 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16713974
NCBI chrNW_004955427:19,489,972...19,671,137
Ensembl chrNW_004955427:19,495,422...19,671,137
G
Gusb
glucuronidase beta
treatment
ISO
RGD
PMID:827200
RGD:42724460
NCBI chrNW_004955456:8,377,161...8,392,298
Ensembl chrNW_004955456:8,378,654...8,392,252
G
Havcr2
hepatitis A virus cellular receptor 2
ISO
mRNA,protein:altered expression:bone:
RGD
PMID:25264706
RGD:9686117
NCBI chrNW_004955408:11,289,920...11,311,216
Ensembl chrNW_004955408:11,291,937...11,311,320
G
Hdac6
histone deacetylase 6
treatment
ISO
RGD
PMID:23541634
RGD:9681550
NCBI chrNW_004955543:348,314...378,391
Ensembl chrNW_004955543:348,019...378,071
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
ISO
RGD
PMID:21679445
RGD:8693318
NCBI chrNW_004955466:8,000,311...8,022,497
Ensembl chrNW_004955466:8,000,044...8,022,497
G
Hmgb1
high mobility group box 1
ISO
protein:altered localization:cytoplasm, extracellular matrix
RGD
PMID:12384917
RGD:728698
NCBI chrNW_004955431:15,373,207...15,377,339
Ensembl chrNW_004955431:15,373,207...15,377,339
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
RGD
PMID:17119970
RGD:5508468
NCBI chrNW_004955425:25,362,165...25,380,611
Ensembl chrNW_004955425:25,359,884...25,380,745
G
Hspd1
heat shock protein family D (Hsp60) member 1
ISO
RGD
PMID:10882416 PMID:15529360
RGD:12910542 RGD:1624244
NCBI chrNW_004955403:3,062,724...3,073,419
Ensembl chrNW_004955403:3,063,133...3,073,419
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:7774621 PMID:12412757 PMID:19203382 PMID:22450443
RGD:10755750 RGD:2311498
NCBI chrNW_004955458:14,643,333...14,648,020
Ensembl chrNW_004955458:14,643,313...14,648,045
G
Igf1
insulin like growth factor 1
ISO
protein:decreased expression:plasma
RGD
PMID:19246225
RGD:2306697
NCBI chrNW_004955405:37,505,830...37,582,152
Ensembl chrNW_004955405:37,512,201...37,582,152
G
Igfbp3
insulin like growth factor binding protein 3
ISO
mRNA, protein:increased expression:kidney, serum
RGD
PMID:14642797
RGD:10402760
NCBI chrNW_004955456:6,795,560...6,802,147
Ensembl chrNW_004955456:6,795,604...6,800,845
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
treatment
ISO
RGD
PMID:19652024 PMID:21087862
RGD:7495772 RGD:7495778
NCBI chrNW_004955536:611,965...658,647
Ensembl chrNW_004955536:612,774...658,647
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
treatment
ISO
RGD
PMID:16684367
RGD:12791276
NCBI chrNW_004955580:1,053,823...1,069,802
Ensembl chrNW_004955580:1,053,823...1,069,802
G
Il10
interleukin 10
treatment
ISO
CTD Direct Evidence: marker/mechanism|therapeutic protein:decreased expression:serum:
CTD RGD
PMID:15270736 PMID:19169271 PMID:19193354 PMID:20974942 PMID:22052031 PMID:22450443 PMID:23140046 More...
RGD:1626677 RGD:2311059 RGD:7193038 RGD:7364838 RGD:8662976
NCBI chrNW_004955406:42,307,789...42,312,255
Ensembl chrNW_004955406:42,307,664...42,312,779
G
Il13
interleukin 13
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:10444273 PMID:11860705 PMID:17665443
RGD:4889497 RGD:8549606
NCBI chrNW_004955408:4,046,406...4,049,795
G
Il15
interleukin 15
ISO
RGD
PMID:20188418
RGD:5000761
NCBI chrNW_004955471:1,496,352...1,583,919
Ensembl chrNW_004955471:1,497,483...1,511,469
G
Il17a
interleukin 17A
treatment
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:serum (rat)
CTD RGD
PMID:20925596 PMID:20974942 PMID:21194185 PMID:23377547
RGD:4781444 RGD:9068936 RGD:9130803
NCBI chrNW_004955411:5,896,435...5,899,911
Ensembl chrNW_004955411:5,896,702...5,900,962
G
Il18
interleukin 18
disease_progression
ISO
RGD
PMID:15147345 PMID:19096963
RGD:4889415 RGD:4889503
NCBI chrNW_004955412:13,807,361...13,826,007
Ensembl chrNW_004955412:13,806,553...13,825,634
G
Il1a
interleukin 1 alpha
ISO
protein:increased expression:serum:
RGD
PMID:19169271 PMID:20379758
RGD:6907373 RGD:8662976
NCBI chrNW_004955470:1,527,710...1,538,418
Ensembl chrNW_004955470:1,527,674...1,538,466
G
Il1b
interleukin 1 beta
treatment
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:serum (rat)
CTD RGD
PMID:19330884 PMID:20131233 PMID:20974942 PMID:21557995 PMID:22450443 PMID:23140046 PMID:24028507 PMID:29408684 More...
RGD:10755447 RGD:13792834 RGD:7175317 RGD:7193038
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
G
Il1rl1
interleukin 1 receptor like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20472598
NCBI chrNW_004955470:7,779,828...7,849,157
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
mouse model treated with human protein mRNA:increased expression:popliteal lymph node (rat) rat model treated with human protein human gene in a rat model
RGD
PMID:10921508 PMID:12727108 PMID:15270736 PMID:22267332 PMID:23006786
RGD:1626677 RGD:6907376 RGD:8549801 RGD:8551741 RGD:8551745
NCBI chrNW_004955470:1,145,022...1,159,413
Ensembl chrNW_004955470:1,144,810...1,159,471
G
Il2
interleukin 2
treatment
ISO
protein:increased expression:serum:
RGD
PMID:2492102 PMID:19169271
RGD:10047055 RGD:8662976
NCBI chrNW_004955428:18,163,010...18,168,157
Ensembl chrNW_004955428:18,162,467...18,168,265
G
Il20
interleukin 20
ISO
RGD
PMID:20722035
RGD:5147393
NCBI chrNW_004955406:42,398,510...42,401,561
Ensembl chrNW_004955406:42,398,782...42,401,490
G
Il2ra
interleukin 2 receptor subunit alpha
ISO
RGD
PMID:17928458
RGD:2325988
NCBI chrNW_004955421:22,642,004...22,694,729
Ensembl chrNW_004955421:22,641,511...22,694,913
G
Il33
interleukin 33
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20472598
NCBI chrNW_004955434:10,145,449...10,187,595
Ensembl chrNW_004955434:10,171,812...10,188,948
G
Il4
interleukin 4
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:10444273 PMID:16869003 PMID:23140046 PMID:23972727
RGD:10402790 RGD:2317300 RGD:7193038
NCBI chrNW_004955408:4,058,052...4,065,999
G
Il6
interleukin 6
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8607900 PMID:10381487 PMID:20131233 PMID:20974942 PMID:22450443 PMID:23503893 PMID:24028507 More...
RGD:10755447 RGD:11049551 RGD:11049553 RGD:11060267
NCBI chrNW_004955410:25,079,835...25,084,390
G
Il6st
interleukin 6 cytokine family signal transducer
ISO
RGD
PMID:20626857
RGD:5509945
NCBI chrNW_004955446:11,790,636...11,837,734
Ensembl chrNW_004955446:11,790,444...11,835,001
G
Itga4
integrin subunit alpha 4
treatment
ISO
RGD
PMID:12969328
RGD:9698440
NCBI chrNW_004955403:15,726,296...15,807,055
Ensembl chrNW_004955403:15,723,785...15,807,111
G
Itgb2
integrin subunit beta 2
ISO
RGD
PMID:8881759
RGD:6482229
NCBI chrNW_004955407:41,779,849...41,805,637
Ensembl chrNW_004955407:41,777,777...41,800,201
G
Itgb3
integrin subunit beta 3
ISO
protein:increased expression:endothelial cell
RGD
PMID:16869003
RGD:2317300
NCBI chrNW_004955478:9,788,192...9,830,254
Ensembl chrNW_004955478:9,788,149...9,823,746
G
Jag1
jagged canonical Notch ligand 1
ISO
RGD
PMID:19265135
RGD:6482234
NCBI chrNW_004955415:20,490,414...20,526,068
Ensembl chrNW_004955415:20,490,414...20,527,917
G
Jak1
Janus kinase 1
treatment
ISO
RGD
PMID:29452839
RGD:19165139
NCBI chrNW_004955423:25,501,989...25,581,826
Ensembl chrNW_004955423:25,524,075...25,580,604
G
Jak2
Janus kinase 2
treatment
ISO
RGD
PMID:22339472 PMID:22800927 PMID:23711144
RGD:10403066 RGD:10403074 RGD:10403081
NCBI chrNW_004955434:9,227,897...9,341,208
Ensembl chrNW_004955434:9,227,595...9,341,208
G
Jak3
Janus kinase 3
treatment
ISO
RGD
PMID:18234077 PMID:21434883 PMID:25762693
RGD:11533938 RGD:11533942 RGD:11533944
NCBI chrNW_004955524:3,399,895...3,412,018
Ensembl chrNW_004955524:3,401,642...3,411,643
G
Kcnn4
potassium calcium-activated channel subfamily N member 4
ameliorates
ISO
RGD
PMID:25131209
RGD:150521609
NCBI chrNW_004955555:1,493,600...1,509,113
Ensembl chrNW_004955555:1,490,052...1,509,113
G
Klkb1
kallikrein B1
ISO
RGD
PMID:9783057 PMID:22739815
RGD:7297047 RGD:7327138
NCBI chrNW_004955403:22,835,544...22,856,355
Ensembl chrNW_004955403:22,833,982...22,856,389
G
Kyat1
kynurenine aminotransferase 1
ISO
RGD
PMID:16984225
RGD:2306289
NCBI chrNW_004955570:1,211,950...1,260,561
Ensembl chrNW_004955570:1,211,160...1,254,303
G
Lep
leptin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15142272
NCBI chrNW_004955479:9,266,604...9,276,568
Ensembl chrNW_004955479:9,274,516...9,279,472
G
Lgals3
galectin 3
ISO
RGD
PMID:16507131
RGD:1625684
NCBI chrNW_004955409:8,448,120...8,452,437
Ensembl chrNW_004955409:8,447,774...8,452,438
G
LOC102021956
alpha-2-macroglobulin
ISO
protein:increased expression:serum
RGD
PMID:6163339
RGD:10046032
NCBI chrNW_004955413:6,019,457...6,062,366
Ensembl chrNW_004955413:6,019,082...6,062,529
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
ISO
RGD
PMID:16331767
RGD:10412332
NCBI chrNW_004955439:162,499...376,919
Ensembl chrNW_004955439:163,103...377,808
G
Mif
macrophage migration inhibitory factor
ISO
RGD
PMID:10765927
RGD:1642012
NCBI chrNW_004955455:8,367,566...8,368,460
Ensembl chrNW_004955455:8,367,566...8,368,460
G
Mmp13
matrix metallopeptidase 13
treatment
ISO
RGD
PMID:11435459 PMID:24244039
RGD:1582329 RGD:8694124
NCBI chrNW_004955412:6,106,994...6,118,760
Ensembl chrNW_004955412:6,106,994...6,118,760
G
Mmp9
matrix metallopeptidase 9
ISO
protein:increased expression:cartilage, serum, synovial fluid
RGD
PMID:17463159
RGD:1642035
NCBI chrNW_004955445:11,295,500...11,303,322
Ensembl chrNW_004955445:11,295,448...11,303,288
G
Mpo
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22450443
NCBI chrNW_004955451:4,743,744...4,753,358
Ensembl chrNW_004955451:4,743,744...4,753,358
G
Mtor
mechanistic target of rapamycin kinase
treatment
ISO
RGD
PMID:22391142
RGD:10041007
NCBI chrNW_004955486:2,487,642...2,599,694
Ensembl chrNW_004955486:2,487,642...2,599,694
G
Myd88
MYD88 innate immune signal transduction adaptor
ISO
RGD
PMID:20131263
RGD:8552884
NCBI chrNW_004955427:25,553,589...25,557,654
Ensembl chrNW_004955427:25,553,589...25,559,138
G
Myod1
myogenic differentiation 1
treatment
ISO
RGD
PMID:23781298
RGD:9686078
NCBI chrNW_004955414:32,523,959...32,526,575
Ensembl chrNW_004955414:32,523,924...32,526,674
G
Myog
myogenin
treatment
ISO
RGD
PMID:23781298
RGD:9686078
NCBI chrNW_004955406:39,099,044...39,102,479
Ensembl chrNW_004955406:39,099,716...39,102,501
G
Ncf1
neutrophil cytosolic factor 1
severity
ISO
DNA:missense mutations:cds:p.M106V, p.M153T (rat)
RGD
PMID:12461526
RGD:628543
NCBI chrNW_004955456:13,353,780...13,363,956
Ensembl chrNW_004955456:13,354,011...13,363,891
G
Nod2
nucleotide binding oligomerization domain containing 2
ISO
RGD
PMID:20131263 PMID:21424514
RGD:5508728 RGD:8552884
NCBI chrNW_004955433:8,746,213...8,780,119
Ensembl chrNW_004955433:8,746,004...8,782,710
G
Nos2
nitric oxide synthase 2
ISO
protein:increased expression:ankle joint (mouse)
RGD
PMID:12826065 PMID:21880869
RGD:1358527 RGD:5509060
NCBI chrNW_004955481:5,197,957...5,232,406
Ensembl chrNW_004955481:5,201,234...5,231,961
G
Nos3
nitric oxide synthase 3
treatment
ISO
RGD
PMID:29337196
RGD:13504725
NCBI chrNW_004955491:5,438,228...5,457,308
Ensembl chrNW_004955491:5,438,010...5,460,814
G
Npsr1
neuropeptide S receptor 1
treatment
ISO
RGD
PMID:24884567
RGD:9831205
NCBI chrNW_004955560:1,069,651...1,243,111
Ensembl chrNW_004955560:1,069,651...1,243,111
G
Nqo1
NAD(P)H quinone dehydrogenase 1
severity
ISO
RGD
PMID:16905546
RGD:11073695
NCBI chrNW_004955484:7,012,373...7,028,182
Ensembl chrNW_004955484:7,012,506...7,027,604
G
Nr1h2
nuclear receptor subfamily 1 group H member 2
ISO
RGD
PMID:21859686
RGD:6480864
NCBI chrNW_004955559:731,630...736,973
Ensembl chrNW_004955559:730,670...737,505
G
Nr1h3
nuclear receptor subfamily 1 group H member 3
ISO
RGD
PMID:21859686
RGD:6480864
NCBI chrNW_004955422:940,310...954,170
Ensembl chrNW_004955422:940,310...949,049
G
Nras
NRAS proto-oncogene, GTPase
ISO
RGD
PMID:18706093
RGD:2300006
NCBI chrNW_004955435:18,001,517...18,009,105
Ensembl chrNW_004955435:18,001,517...18,009,103
G
Nts
neurotensin
ISO
RGD
PMID:8518953
RGD:9743903
NCBI chrNW_004955405:23,696,258...23,758,487
Ensembl chrNW_004955405:23,748,280...23,758,529
G
Orm1
orosomucoid 1
ISO
protein:increased expression:liver
RGD
PMID:16166348
RGD:2316639
NCBI chrNW_004955419:13,262,119...13,264,986
G
P2ry12
purinergic receptor P2Y12
ISO
RGD
PMID:22028806
RGD:6480518
NCBI chrNW_004955448:2,442,368...2,488,567
Ensembl chrNW_004955448:2,442,368...2,488,567
G
Pam
peptidylglycine alpha-amidating monooxygenase
ISO
RGD
PMID:17138865
RGD:6483527
NCBI chrNW_004955418:10,953,044...11,107,668
Ensembl chrNW_004955418:10,953,696...11,107,667
G
Parp1
poly(ADP-ribose) polymerase 1
severity
ISO
RGD
PMID:16356201
RGD:5684009
NCBI chrNW_004955489:520,875...557,609
Ensembl chrNW_004955489:520,875...557,615
G
Pdyn
prodynorphin
treatment
ISO
RGD
PMID:25102697
RGD:401851905
NCBI chrNW_004955415:13,106,087...13,119,497
Ensembl chrNW_004955415:13,106,062...13,119,515
G
Pecam1
platelet and endothelial cell adhesion molecule 1
severity
ISO
protein:increased expression:knee joint, blood vessels (mouse)
RGD
PMID:14613294 PMID:21982514 PMID:22548760
RGD:6484738 RGD:6771177 RGD:6771222
NCBI chrNW_004955478:7,448,584...7,531,860
Ensembl chrNW_004955478:7,478,492...7,531,188
G
Pgf
placental growth factor
ISO
RGD
PMID:19180491
RGD:6483591
NCBI chrNW_004955523:616,196...627,055
Ensembl chrNW_004955523:616,154...627,713
G
Pik3cd
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
ISO
RGD
PMID:18412166
RGD:6482696
NCBI chrNW_004955486:3,813,923...3,837,563
Ensembl chrNW_004955486:3,813,923...3,838,119
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
ISO
RGD
PMID:18412166 PMID:20374644
RGD:6482684 RGD:6482696
NCBI chrNW_004955410:11,402,476...11,433,335
Ensembl chrNW_004955410:11,402,520...11,437,422
G
Plau
plasminogen activator, urokinase
ISO
RGD
PMID:20973954
RGD:6483801
NCBI chrNW_004955437:17,995,726...18,000,542
Ensembl chrNW_004955437:17,994,537...18,000,209
G
Pomc
proopiomelanocortin
treatment
ISO
RGD
PMID:25102697
RGD:401851905
NCBI chrNW_004955469:7,217,233...7,220,401
Ensembl chrNW_004955469:7,217,363...7,220,386
G
Prdm1
PR/SET domain 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36181686
NCBI chrNW_004955411:31,434,503...31,455,995
Ensembl chrNW_004955411:31,434,503...31,456,056
G
Ptch1
patched 1
treatment
ISO
RGD
PMID:25821409
RGD:12879456
NCBI chrNW_004955422:22,362,330...22,418,062
Ensembl chrNW_004955422:22,362,221...22,427,622
G
Ptger4
prostaglandin E receptor 4
disease_progression treatment
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:tarsal joint, synovium (rat)
CTD RGD
PMID:11207665 PMID:18287210 PMID:20423341
RGD:10003041 RGD:10003052 RGD:10043377
NCBI chrNW_004955426:24,997,811...25,010,822
Ensembl chrNW_004955426:24,997,811...25,010,822
G
Ptges
prostaglandin E synthase
ISO
mRNA, protein:increased expression:paw
RGD
PMID:12707354
RGD:2300108
NCBI chrNW_004955445:10,053,745...10,056,981
G
Ptges3
prostaglandin E synthase 3
ISO
mRNA:increased expression:paw (rat)
RGD
PMID:12707354
RGD:2300108
NCBI chrNW_004955458:4,203,075...4,209,967
Ensembl chrNW_004955458:4,203,076...4,209,910
G
Ptgs1
prostaglandin-endoperoxide synthase 1
ISO
mRNA, protein:increased expression:synovium
RGD
PMID:22289897
RGD:5687744
NCBI chrNW_004955419:5,678,750...5,699,305
Ensembl chrNW_004955419:5,678,694...5,699,305
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
mRNA, protein:increased expression:synovium protein:increased expression:autopod joint
RGD
PMID:18758904 PMID:21765105 PMID:22289897
RGD:2300221 RGD:5508310 RGD:5687744
NCBI chrNW_004955406:25,077,988...25,086,259
Ensembl chrNW_004955406:25,079,945...25,086,171
G
Ptpn22
protein tyrosine phosphatase non-receptor type 22
ISO
protein:increased expression:metatarsophalangeal joint, mononuclear cell (rat)
RGD
PMID:24998229
RGD:11532752
NCBI chrNW_004955435:17,082,762...17,139,067
G
Rag2
recombination activating 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20974942
NCBI chrNW_004955422:9,867,307...9,869,732
Ensembl chrNW_004955422:9,867,307...9,869,732
G
S100a9
S100 calcium binding protein A9
ISO
RGD
PMID:8343166
RGD:633930
NCBI chrNW_004955592:90,647...93,842
G
Serpinc1
serpin family C member 1
ISO
protein:decreased expression:plasma
RGD
PMID:22781611
RGD:11035273
NCBI chrNW_004955406:14,024,183...14,036,206
Ensembl chrNW_004955406:14,024,313...14,035,948
G
Sfrp4
secreted frizzled related protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25194984
NCBI chrNW_004955460:5,654,187...5,666,475
Ensembl chrNW_004955460:5,654,288...5,664,219
G
Shh
sonic hedgehog signaling molecule
treatment
ISO
RGD
PMID:25821409
RGD:12879456
NCBI chrNW_004955491:8,647,133...8,657,381
G
Slc11a1
solute carrier family 11 member 1
severity
ISO
RGD
PMID:17122779
RGD:5684943
NCBI chrNW_004955453:14,980,562...14,995,118
Ensembl chrNW_004955453:14,980,562...14,995,608
G
Smo
smoothened, frizzled class receptor
treatment
ISO
RGD
PMID:25821409
RGD:12879456
NCBI chrNW_004955479:9,963,377...9,991,670
Ensembl chrNW_004955479:9,964,170...9,993,165
G
Socs3
suppressor of cytokine signaling 3
ISO
mRNA:increased expression:mononuclear cell
RGD
PMID:16507131
RGD:1625684
NCBI chrNW_004955506:4,222,455...4,225,563
Ensembl chrNW_004955506:4,222,455...4,225,563
G
Spn
sialophorin
ISO
associated with Staphylococcal Infections
RGD
PMID:7927732
RGD:2303983
NCBI chrNW_004955493:7,256,505...7,258,607
G
Stat1
signal transducer and activator of transcription 1
ISO
CTD Direct Evidence: marker/mechanism protein:increased tyrosine phosphorylation:macrophage, synovial cell
CTD RGD
PMID:14674010 PMID:15188379
RGD:1582346
NCBI chrNW_004955403:8,156,660...8,192,018
Ensembl chrNW_004955403:8,156,660...8,194,762
G
Stat3
signal transducer and activator of transcription 3
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15188379 PMID:21937456 PMID:23711144
RGD:10403081
NCBI chrNW_004955451:16,320,326...16,348,505
Ensembl chrNW_004955451:16,319,904...16,357,687
G
Tac1
tachykinin precursor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9259450
NCBI chrNW_004955432:13,991,647...13,999,665
Ensembl chrNW_004955432:13,991,414...13,999,728
G
Tgfb1
transforming growth factor beta 1
ISO
RGD
PMID:29763498
RGD:15036801
NCBI chrNW_004955555:274,405...288,441
Ensembl chrNW_004955555:270,652...288,441
G
Tgfbr2
transforming growth factor beta receptor 2
ISO
protein:increased expression:synovium
RGD
PMID:9010265
RGD:1601623
NCBI chrNW_004955430:21,919,338...21,999,688
Ensembl chrNW_004955430:21,932,553...22,001,837
G
Thbd
thrombomodulin
ISO
RGD
PMID:16879225
RGD:5685015
NCBI chrNW_004955415:30,222,830...30,226,406
G
Timp4
TIMP metallopeptidase inhibitor 4
ISO
RGD
PMID:12483743
RGD:2290463
NCBI chrNW_004955429:14,689,016...14,693,211
Ensembl chrNW_004955429:14,685,031...14,693,211
G
Tjp1
tight junction protein 1
ISO
RGD
PMID:18848892
RGD:2325138
NCBI chrNW_004955416:28,640,807...28,869,717
Ensembl chrNW_004955416:28,654,905...28,870,555
G
Tlr2
toll like receptor 2
ISO
RGD
PMID:20131263 PMID:21725847
RGD:7241099 RGD:8552884
NCBI chrNW_004955471:8,011,710...8,019,063
Ensembl chrNW_004955471:8,014,910...8,017,258
G
Tlr3
toll like receptor 3
ISO
RGD
PMID:20500834
RGD:5128706
NCBI chrNW_004955403:22,977,882...23,001,392
Ensembl chrNW_004955403:22,979,120...23,001,467
G
Tnf
tumor necrosis factor
treatment
ISO
protein:increased expression:serum: CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:7589090 PMID:9598899 PMID:19169271 PMID:19203382 PMID:19330884 PMID:19765281 PMID:20131233 PMID:20974942 PMID:21452922 PMID:21690068 PMID:22450443 PMID:23052485 PMID:23140046 PMID:24028507 PMID:24394943 PMID:29408684 More...
RGD:10450611 RGD:10755447 RGD:13792834 RGD:7193038 RGD:7245941 RGD:8661761 RGD:8662976
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
G
Tnfrsf11b
TNF receptor superfamily member 11b
treatment
ISO
CTD Direct Evidence: therapeutic Sinomenine CHEBI:9163 mRNA:decreased expression:bone
CTD RGD
PMID:16696922 PMID:23333834 PMID:24066131
RGD:1624171 RGD:42721982
NCBI chrNW_004955417:24,804,708...24,831,338
Ensembl chrNW_004955417:24,804,664...24,831,894
G
Tnfrsf1a
TNF receptor superfamily member 1A
treatment
ISO
RGD
PMID:20370892 PMID:21690068 PMID:23052485
RGD:7245941 RGD:8661729 RGD:8661761
NCBI chrNW_004955413:3,982,670...3,996,320
Ensembl chrNW_004955413:3,981,400...3,996,021
G
Tnfrsf1b
TNF receptor superfamily member 1B
treatment
ISO
human protein in rat model
RGD
PMID:21463515 PMID:21690068 PMID:23052485
RGD:5131255 RGD:7245941 RGD:8661761
NCBI chrNW_004955486:1,790,531...1,817,986
Ensembl chrNW_004955486:1,792,115...1,818,362
G
Txndc5
thioredoxin domain containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326410
NCBI chrNW_004955465:6,034,006...6,053,779
Ensembl chrNW_004955465:6,033,968...6,053,769
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9598899 PMID:26221077
NCBI chrNW_004955437:9,527,445...9,541,908
G
Vim
vimentin
ISO
RGD
PMID:7516431
RGD:6480480
NCBI chrNW_004955429:10,708,852...10,716,743
Ensembl chrNW_004955429:10,707,719...10,717,554
G
Vip
vasoactive intestinal peptide
ISO
RGD
PMID:19055696 PMID:21998117
RGD:5685376 RGD:5685612
NCBI chrNW_004955439:9,021,923...9,031,783
Ensembl chrNW_004955439:9,021,904...9,031,792
G
Xylt1
xylosyltransferase 1
ISO
mRNA:decreased expression:articular cartilage
RGD
PMID:19001053
RGD:2313142
NCBI chrNW_004955442:1,787,338...2,042,523
Ensembl chrNW_004955442:1,745,924...2,036,340
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all